REGULATION OF SKELETAL DEVELOPMENT BY PERK eIF2-ALPHA KINASE
PERK eIF2-α 激酶对骨骼发育的调节
基本信息
- 批准号:7383821
- 负责人:
- 金额:$ 29.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-03-15 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressBiochemicalBone and Cartilage FundingCellsChondrocytesCollagenCollagen Type ICoupledDefectEmbryoEpiphysial cartilageEventExtracellular MatrixFibroblastsFutureGene ExpressionGenerationsGenesGoalsGrowthGrowth and Development functionHereditary DiseaseHumanHydroxylationKnock-outKnockout MiceLinkLocalizedMolecularMusMutationNatureOsteoblastsOsteoporosisPathway interactionsPeptide Initiation FactorsPhosphotransferasesProcessProcollagenProlineProtein BiosynthesisProteinsRegulationResearch PersonnelRoleSecretory CellSkeletal DevelopmentSkeletal systemTissuesTransgenesTransgenic OrganismsType I ProcollagenWolcott-Rallison syndromebaseextracellularlong bonepostnatalprogramsresearch studysecretory proteinskeletal dysplasiatibia
项目摘要
DESCRIPTION (provided by applicant): Skeletal development, growth and remodeling are highly dependent upon the dynamic regulation of protein synthesis and secretion inasmuch as cartilage and bone are largely extracellular and composed of collagens plus a variety of other secreted proteins. The synthesis and secretion of collagens and noncollagenous extracellular matrix arise from the major secretory cells of the skeletal system, osteoblasts and chondrocytes. Currently little is known of how the regulation of synthesis of secretory proteins and their secretion are coupled in these cells. We have shown that the PERK eIF2alpha kinase, a regulator of a key translation initiation factor, is essential for the development and growth of the skeletal system. We postulate that PERK is a key regulator of molecular events that control the secretory processes of chondrocytes and osteoblasts. We propose to determine the mechanism of PERK-dependent regulation of type I collagen synthesis and secretion, to identify the molecular defects that underlie the deficient extracellular matrix in the hypertrophic zone in the growth plate of Perk-/- mice, and to determine the cellular basis of the skeletal dysplasias observed in the Perk-/- knockout mice. These studies are directly related to understanding the molecular basis of osteoporosis in the human Wolcott-Rallison syndrome, a genetic disease linked to the human Perk gene that shows the same array of skeletal defects seen in the Perk-/- knockout mice.
描述(由申请人提供):骨发育、生长和重塑高度依赖于蛋白质合成和分泌的动态调节,因为软骨和骨主要是细胞外的,并且由胶原蛋白加上多种其他分泌蛋白组成。胶原和非胶原性细胞外基质的合成和分泌来自骨骼系统的主要分泌细胞,成骨细胞和软骨细胞。目前,很少有人知道如何在这些细胞中的分泌蛋白的合成和分泌的调控耦合。我们已经表明,PERK eIF 2 α激酶,一个关键的翻译起始因子的调节,是必不可少的骨骼系统的发育和生长。我们假设PERK是控制软骨细胞和成骨细胞分泌过程的分子事件的关键调节因子。我们建议,以确定的机制PERK依赖的调节I型胶原蛋白的合成和分泌,以确定的分子缺陷的基础上缺乏细胞外基质在肥大区的生长板的Perk-/-小鼠,并确定在Perk-/-敲除小鼠中观察到的骨骼发育不良的细胞基础。这些研究与理解人类Wolcott-Rallison综合征中骨质疏松症的分子基础直接相关,这是一种与人类Perk基因相关的遗传疾病,显示出与Perk-/-敲除小鼠相同的骨骼缺陷阵列。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DOUGLAS R. CAVENER其他文献
DOUGLAS R. CAVENER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DOUGLAS R. CAVENER', 18)}}的其他基金
Physiological Regulation of Proinsulin Quality and Quantity Control in the Pancre
胰腺中胰岛素原质量和数量控制的生理调节
- 批准号:
8495328 - 财政年份:2010
- 资助金额:
$ 29.44万 - 项目类别:
Physiological Regulation of Proinsulin Quality and Quantity Control in the Pancre
胰腺中胰岛素原质量和数量控制的生理调节
- 批准号:
8050218 - 财政年份:2010
- 资助金额:
$ 29.44万 - 项目类别:
Physiological Regulation of Proinsulin Quality and Quantity Control in the Pancre
胰腺中胰岛素原质量和数量控制的生理调节
- 批准号:
8149900 - 财政年份:2010
- 资助金额:
$ 29.44万 - 项目类别:
Physiological regulation of proinsulin in the pancreatic beta cell
胰腺β细胞中胰岛素原的生理调节
- 批准号:
8310231 - 财政年份:2010
- 资助金额:
$ 29.44万 - 项目类别:
Perk eIF2a Kinase Integrates Proinsulin Quality Control and Insulin Secretion
Perk eIF2a 激酶整合胰岛素原质量控制和胰岛素分泌
- 批准号:
9274953 - 财政年份:2010
- 资助金额:
$ 29.44万 - 项目类别:
Perk eIF2a Kinase Integrates Proinsulin Quality Control and Insulin Secretion
Perk eIF2a 激酶整合胰岛素原质量控制和胰岛素分泌
- 批准号:
9088398 - 财政年份:2010
- 资助金额:
$ 29.44万 - 项目类别:
REGULATION OF SKELETAL DEVELOPMENT BY PERK eIF2-ALPHA KINASE
PERK eIF2-α 激酶对骨骼发育的调节
- 批准号:
6868169 - 财政年份:2004
- 资助金额:
$ 29.44万 - 项目类别:
REGULATION OF SKELETAL DEVELOPMENT BY PERK eIF2-ALPHA KINASE
PERK eIF2-α 激酶对骨骼发育的调节
- 批准号:
6731014 - 财政年份:2004
- 资助金额:
$ 29.44万 - 项目类别:
REGULATION OF SKELETAL DEVELOPMENT BY PERK eIF2-ALPHA KINASE
PERK eIF2-α 激酶对骨骼发育的调节
- 批准号:
7196420 - 财政年份:2004
- 资助金额:
$ 29.44万 - 项目类别:
相似海外基金
CAREER: Biochemical and Structural Mechanisms Controlling tRNA-Modifying Metalloenzymes
职业:控制 tRNA 修饰金属酶的生化和结构机制
- 批准号:
2339759 - 财政年份:2024
- 资助金额:
$ 29.44万 - 项目类别:
Continuing Grant
Systematic manipulation of tau protein aggregation: bridging biochemical and pathological properties
tau 蛋白聚集的系统操作:桥接生化和病理特性
- 批准号:
479334 - 财政年份:2023
- 资助金额:
$ 29.44万 - 项目类别:
Operating Grants
Diurnal environmental adaptation via circadian transcriptional control based on a biochemical oscillator
基于生化振荡器的昼夜节律转录控制的昼夜环境适应
- 批准号:
23H02481 - 财政年份:2023
- 资助金额:
$ 29.44万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Leveraging releasable aryl diazonium ions to probe biochemical systems
利用可释放的芳基重氮离子探测生化系统
- 批准号:
2320160 - 财政年份:2023
- 资助金额:
$ 29.44万 - 项目类别:
Standard Grant
Biochemical Mechanisms for Sustained Humoral Immunity
持续体液免疫的生化机制
- 批准号:
10637251 - 财政年份:2023
- 资助金额:
$ 29.44万 - 项目类别:
Structural and biochemical investigations into the mechanism and evolution of soluble guanylate cyclase regulation
可溶性鸟苷酸环化酶调节机制和进化的结构和生化研究
- 批准号:
10604822 - 财政年份:2023
- 资助金额:
$ 29.44万 - 项目类别:
Enhanced Biochemical Monitoring for Aortic Aneurysm Disease
加强主动脉瘤疾病的生化监测
- 批准号:
10716621 - 财政年份:2023
- 资助金额:
$ 29.44万 - 项目类别:
Converting cytoskeletal forces into biochemical signals
将细胞骨架力转化为生化信号
- 批准号:
10655891 - 财政年份:2023
- 资助金额:
$ 29.44万 - 项目类别:
Chemical strategies to investigate biochemical crosstalk in human chromatin
研究人类染色质生化串扰的化学策略
- 批准号:
10621634 - 财政年份:2023
- 资助金额:
$ 29.44万 - 项目类别:
Examination of risk assessment and biochemical assessment of fracture development focusing on the body composition of patients with rheumatoid arthritis
关注类风湿性关节炎患者身体成分的骨折发生风险评估和生化评估检查
- 批准号:
22KJ2600 - 财政年份:2023
- 资助金额:
$ 29.44万 - 项目类别:
Grant-in-Aid for JSPS Fellows